Skip to main content

Table 2 Serial hematocrit measurements in rats after MI, showing that EPO-transduced cell injection does not increase systemic hematocrit levels

From: Transplantation of genetically engineered cardiac fibroblasts producing recombinant human erythropoietin to repair the infarcted myocardium

Treatment time Saline (n = 9) EPO-transduced cells (n = 9) Non-transduced cells (n = 9)
Baseline (before injection; %) 47.5 ± 0.3 47.2 ± 0.2 47.2 ± 0.1
1 week post-injection (%) 47.4 ± 0.2 47.0 ± 0.1 47.39 ± 0.2
4 weeks post-injection (%) 47.4 ± 0.18 46.8 ± 0.2 47.15 ± 0.2
  1. p = 1.00.
\